Inozyme Pharma Inc

NASDAQ:INZY   3:09:40 PM EDT
1.49
-0.06 (-3.87%)
Earnings Announcements

Inozyme Pharma Reports Third Quarter Results

Published: 11/10/2022 16:44 GMT
Inozyme Pharma Inc (INZY) - Inozyme Pharma Reports Third Quarter 2022 Financial Results and Provides Business Updates.
Q3 Loss per Share $0.38.
Inozyme -expects Cash, Cash Equivalents,investments, Remainder of First Tranche of Debt Facility to Enable Fund Cash Flow Requirements Into Q2 2024.
Q3 Earnings per Share View $-0.43 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.46

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.40

More details on our Analysts Page.